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ABSTRACT
While the biomedical community has published several “open data” sources in the last decade, most researchers still endure
severe logistical and technical challenges to discover, query, and integrate heterogeneous data and knowledge from multiple
sources. To tackle these challenges, the community has experimented with Semantic Web and linked data technologies to
create the Life Sciences Linked Open Data (LSLOD) cloud. In this paper, we extract schemas from more than 80 publicly
available biomedical linked data graphs into an LSLOD schema graph and conduct an empirical meta-analysis to evaluate
the extent of semantic heterogeneity across the LSLOD cloud. We observe that several LSLOD sources exist as stand-alone
data sources that are not inter-linked with other sources, use unpublished schemas with minimal reuse or mappings, and have
elements that are not useful for data integration from a biomedical perspective. We envision that the LSLOD schema graph
and the findings from this research will aid researchers who wish to query and integrate data and knowledge from multiple
biomedical sources simultaneously on the Web.
Introduction
Over the last decade, the biomedical research community has published and made available, on the Web, several sources
consisting of biomedical data and knowledge: anonymized medical records1, imaging data2, sequencing data3, biomedical
publications4, biological assays5, chemical compounds and their activities6, biological molecules and their characteristics7,
knowledge encoded in biological pathways8, 9, animal models10, drugs and their protein targets11, medical knowledge on organs,
symptoms, diseases, and adverse reactions12, etc. However, biomedical researchers still face severe logistical and technical
challenges to integrate, analyze, and visualize heterogeneous data and knowledge from these diverse and often isolated sources.
Researchers need to be aware of the availability and accessibility of these sources on the Web, and need extensive computational
skills and knowledge to query and explore them. To systematically consume and integrate the data and knowledge from these
sources for use in their analyses, researchers often spend a significant amount of their time dealing with the heterogeneous
syntaxes, structures, formats, schemas, and biomedical entity notations used across these sources.
The complexity and time in inter-disciplinary scientific research drastically increase as the biomedical researcher ends
up learning multiple systems, configurations, and means to reconcile similar entities across different sources. In most cases,
the biomedical researcher just wishes to retrieve relevant data pertaining to their unique criteria or to retrieve answers to
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specific queries, such as “What are the medications prescribed to melanoma patients who have a V600E mutation in their
BRAF gene?”, or “List molecular characteristics of antineoplastic drugs that target Estrogen Receptor α and have molecular
weight less than 300 g/mol”. However, due to the current state of the biomedical data and knowledge landscape with multiple,
isolated, heterogeneous sources, the researcher has to hop across several Web portals (e.g., Pubchem5) and search engines (e.g.,
PubMed4) for these tasks.
Semantic Web and linked data technologies are deemed to be promising solutions to tackle these challenges, and enable
toward Web-scale data and knowledge integration and semantic processing in several biomedical domains, such as pharmacology
and cancer research13. Biomedical researchers have been some of the earliest adopters of these technologies, and have used
them to drive knowledge management, semantic search, clinical decision support, rule-based decision making, enrichment
analysis, data annotation, and data integration. Moreover, these technologies are used to represent data and knowledge stored in
isolated, heterogeneous sources on the Web to create a network of “linked knowledge graphs”, often referred to as the Life
Sciences Linked Open Data (LSLOD) cloud13. A diagrammatic representation of the LSLOD cloud can be found as part of the
popular Linked Open Data cloud diagram1. These technologies have matured enough that they are also being widely adopted
by several companies, and subsets of the generated knowledge graphs are used in biomedical applications (e.g., Google14,
IBM15, Elsevier16, NuMedii17, Pfizer18, etc.). Semantic Web technologies could also be combined with natural language
processing-based relation extraction methods to systematically extract scientific relations between biomedical entities and to
make them available for querying and consumption through a structured representation of the knowledge graph16, 19.
Ideally, the LSLOD cloud should serve as an open Web-based scalable infrastructure through which biomedical researchers
can query, retrieve, integrate, and analyze data and knowledge from multiple sources, without the requirement on the part
of the researchers to download and manually integrate those sources and be concerned with the location, heterogeneous
schemas, syntaxes, varying entity notations, representations, or the mappings to reconcile similar concepts, relations, and
entities between these sources. However, it is well known that the LSLOD cloud has several shortcomings for this vision to be
achieved. Specifically, most biomedical researchers find it difficult to query and integrate data and knowledge from the LSLOD
cloud for use in their downstream applications, since the LSLOD cloud faces a set of challenges similar to those that it had
set out to solve in the first place13. The rampant semantic heterogeneity across the sources in the LSLOD cloud, due to the
heterogeneous schemas, the varying entity notations, the lack of mappings between similar entities, and the lack of reuse of
common vocabularies, leads to the question on whether the LSLOD cloud can truly be considered “linked”.
In this paper, we present our results on an empirical meta-analysis conducted on more than 80 data and knowledge sources
in the Life Sciences Linked Open Data (LSLOD) cloud. The main contributions of this research can be outlined as follows:
1. Using an approach to automatically extract schemas and vocabularies from a set of publicly available linked data
endpoints that expose biomedical data and knowledge sources on the Web, we have created an LSLOD schema graph
encapsulating content from more than 80 sources.
2. We estimate the extent of reuse of content in LSLOD sources from popular ontologies and vocabularies, as well as the
level of intra-linking and inter-linking across different LSLOD sources.
3. Combining methods of similarity computation and community detection based on word embeddings, we identify
communities of similar content across the LSLOD cloud.
1https://lod-cloud.net/
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We believe that the resources and findings established through this meta-analysis will aid both: i) the biomedical researchers,
who wish to query and use data and knowledge from LSLOD cloud in their applications, and ii) the Semantic Web researchers,
who can develop methods and tools to increase reuse and reduce semantic heterogeneity across the LSLOD cloud, as well as
develop efficient federated querying mechanisms over the LSLOD cloud to handle heterogeneous schemas and diverse entity
notations. In subsequent sections of this paper, we provide a brief overview on the Semantic Web technologies and the Life
Sciences Linked Open Data (LSLOD) cloud, delve deeper into the different biomedical data and knowledge sources that were
used in this research, and provide an overview on the different methods used to extract schemas and vocabularies from publicly
available linked data graphs and to evaluate the reuse and similarity of content across the LSLOD cloud. We will present the
results from this empirical meta-analysis of the quality, reuse, linking, and heterogeneity across the LSLOD cloud, summarize
some of our key findings and observations on the state of biomedical linked data on the Web, and discuss what it means moving
forward on the querying and consumption of data and knowledge on the Web in biomedical applications, in a more systematic
and integrated fashion. The LSLOD schema graph and other pertinent data, as well as the results and visualizations from this
meta-analysis are made available online at http://onto-apps.stanford.edu/lslodminer.
Background and Related Work
Semantic Web Technologies and Life Sciences Linked Open Data
The Linked Open Data cloud was conceived from a vision that a decentralized, distributed, and heterogeneous data space,
extending over the traditional Web (i.e., World Wide Web, or Web of Documents), can reveal hidden associations that were not
directly observable20. To achieve this vision, the Semantic Web community has developed several standards, languages, and
technologies that aim to provide a common framework for data and knowledge representation — linking, sharing, and querying,
across application, enterprise, and community boundaries. Semantic Web languages and technologies have been used to
represent and link data and knowledge sources from several different fields such as life sciences, geography, economics, media,
and statistics, to essentially create a linked network of these sources and to provide a scalable infrastructure for structured
querying of multiple heterogeneous sources simultaneously, for Web-scale computation, and for seamless integration of big
data.
Some Semantic Web languages and technologies have been standardized and recommended by the World Wide Web
Consortium (W3C) and are also widely used by the biomedical community to create the Life Sciences Linked Open Data
(LSLOD) cloud. For example, The Resource Description Framework (RDF), a simple, standard triple-based model for
data interchange on the Web, is used to represent information resources (e.g., biomedical entities, relations, classes) as
linked graphs on the LSLOD cloud21. Each resource is uniquely represented using a HTTP Uniform Resource Identifier
(URI), so that users can view information pertaining to that resource using a Web browser (i.e., Web-dereferenceable).
An example of an HTTP URI from the linked data graph of DrugBank — a knowledge base of drugs and their protein
targets11 — is http://bio2rdf.org/drugbank:DB00619, where http://bio2rdf.org/drugbank: is considered to be the
URI namespace – a declarative region that provides a scope to the identifiers, and DB00619 is the specific identifier of the drug
GLEEVEC. RDF extends the linking structure of the Web by using the URIs to represent relations between two resources.
Hence, RDF facilitates integration and discovery of relevant data and knowledge on the Web even if the schemas and syntaxes
of the underlying data sources differ.
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The vocabularies and schemas of biomedical RDF graphs are generally annotated by the elements from the Resource
Description Framework Schema (RDFS) language22. Similarly, in the last few years, the biomedical community has adopted
the Web Ontology Language (OWL) as the consensus knowledge representation language to develop biomedical ontologies23.
RDFS vocabularies and OWL ontologies enable the modeling of any domain in the world by explicitly describing existing
entities, their attributes and the relationships among these entities. These entities and relationships are usually classified in
specialization or generalization hierarchies. An ontology also contains logical definitions of its terms, along with additional
relations, to facilitate advanced search functionalities24. Whereas, RDF is essentially only a triple-based, schema-less modeling
language, semantics expressed in RDFS vocabularies and OWL ontologies can be exploited by computer programs, called
reasoners, to verify the consistency of assertions in an RDF graph and to generate novel inferences13.
After the data and knowledge sources have been published as linked data using the RDF triple-based model, with semantics
encoded using the RDFS and OWL languages, the SPARQL graph query language can be used to query across multiple diverse
sources using federated architectures25–27. While this distributed querying approach is inspired from the relational database
community, SPARQL query federation architectures leverage the advantages provided by the graphical, uniform syntax, and
schema-less nature of RDF to achieve query federation with minimal effort.
Representative Example on Use of Semantic Web Technologies in Biomedicine
Using Figure 1, we give a more concrete real-world example on the use of Semantic Web technologies for representing data in
the Kyoto Encyclopedia of Genes and Genomes (KEGG) — an integrated data source consisting of several databases, broadly
categorized into biological pathways, proteins, and drugs9 – and linking the different biomedical entities to similar entities in
other biomedical sources, such as DrugBank11, PubMed4, and Gene Ontology — a unified representation of gene and gene
product attributes across all species28.
kegg:Drug2, kegg:Protein, and kegg:Compound are all RDFS classes in the KEGG vocabulary (Figure 1A). kegg:Drug
is a subclass of kegg:Compound (shown using rdfs:subClassOf). kegg:inhibit and kegg:target are both RDFS proper-
ties, with kegg:inhibit being a sub-property of kegg:target (shown using rdfs:subPropertyOf in Figure 1C). Using
a reasoning-enabled query engine, a user who queries for kegg:Compound entities should retrieve all kegg:Drug entities, as
well as all non-drug compounds. Similarly, all queries that look for kegg:target relations should retrieve all kegg:inhibit
relations, along with non-inhibiting interactions. The domain and range of the properties are also shown using the • andI arrow
heads respectively. The KEGG RDF Graph can be aligned to this KEGG RDFS vocabulary, with a class (e.g., kegg:Drug)
instantiated with corresponding instances (e.g., kegg:D01441 (GLEEVEC)) using the rdf:type construct, and properties
realized as property assertions between different instances (e.g., kegg:pathway assertion between kegg:hsa_5156 (PDGFR)
and kegg:map04020 (CA2+ SIGNALING PATHWAY)). These property assertions are shown using red arrows (Figure 1B).
Figure 1B also shows an example of RDF reification, where a blank node (represented using a black colored node) is used
to capture and represent additional information on the interaction between the drug GLEEVEC and the receptor protein PDGFR,
involved in regulating cell growth and implicated in cancer. The blank node links the additional information to a publication
with a URI from a PubMed linked data graph. Object properties (e.g., kegg:pathway) generally have rdfs:Class classes as
domains and ranges, whereas data properties (e.g., kegg:mol_weight) link an rdfs:Class to a datatype (e.g., xsd:Float is
the datatype for float numbers).
2kegg:Drug is a concise representation for a URI http://bio2rdf.org/kegg:Drug.
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Figure 1. Diagrammatic representation to depict annotated RDF graphs. The KEGG RDF graph whose vocabulary is
annotated using RDFS constructs and classes from the Gene Ontology. A) The T -Box consists of the terminological
component of the KEGG RDF Graph (i.e., the vocabulary). The pink nodes represent the different classes from KEGG and
other RDF graph vocabularies (e.g., drugbank:Drug) annotated with rdfs:Class construct. The blue nodes represent the
different properties annotated with rdf:Property (with associated domain and range classes). B) The A-Box consists of the
assertional component of the KEGG RDF graphs, with different individuals (e.g., kegg:D01441) explicitly typed with
corresponding classes from T -Box. C) TheR-Box (relational component) consists of the property hierarchy. D) The KEGG
individual (pathway CA2+ SIGNALING PATHWAY)) may be cross-linked to the corresponding Gene Ontology class, causing a
semantic mismatch (i.e., a class is considered equivalent to an individual).
RDF graphs, annotated using the RDFS language, can be divided into two main components: the terminological component
T -Box and the assertional component A-Box (Figure 1). The T -Box consists of only the axioms pertaining to the vocabulary
or schema (e.g. rdfs:Class, rdfs:subClassOf axioms, along with other logical combination constructs). The A-Box
consists of axioms pertaining to the individuals and their property assertions. RDF graphs (and their associated vocabularies)
can be exposed through SPARQL endpoints on the LSLOD cloud for programmatic access.
In general, classes, properties, and instances in RDF graphs may be cross-linked with elements from external ontologies
and vocabularies, and making such linkages is often considered a best practice when modeling and publishing datasets
as Linked Open Data29. For example, the pathway CA2+ SIGNALING PATHWAY is represented as a class in the Gene
ontology (GO:0019722), but it is represented as an individual (instance) of the kegg:Pathway class in the KEGG RDF Graph
(kegg:map04020) in Figure 1C,D. However, due to the simplistic triple-based nature of RDF, the KEGG individual can be
cross-linked to the Gene Ontology class (this particular situation is often called semantic mismatch, where a class is considered
equivalent to an individual).
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Semantic Heterogeneity across Linked Data Graphs
Entity reconciliation and integrated querying are major problems in biomedicine, as there is often no agreement on a unique
representation of a given entity or a class of entities. Many biomedical entities are referred to by multiple labels, and the same
labels may be used to refer to different entities. For example, different gene entities could be represented using Ensembl30,
Entrez Gene31, and Hugo Gene Nomenclature Committee (HGNC)32 identifiers.
One of the key principles for publishing linked data (LD) is the use of HTTP Uniform Resource Identifiers (URIs) for
entity reconciliation and integrated querying. Each entity (e.g., LEPIRUDIN), or a class (e.g., DRUG), should be represented
uniquely using one unique URI and other publishers should reuse that URI in their datasets. However, most data publishers
create their own URIs by combining the entity IDs from the underlying data sources (e.g., GLEEVEC DrugBank ID DB00619)
with a unique namespace (e.g. http://bio2rdf.org/drugbank:) to represent entities. To resolve the problem of entity
reconciliation, efforts such as Bio2RDF33 and Linking Open Drug Data34 have released guidelines for using cross-reference
x-ref attributes rather than using the same URI. Similar entities in different sources should be mapped to each other (e.g.,
drugbank:DB00619←−−→
x−re f
kegg:D01441 to map GLEEVEC entities in DrugBank and KEGG), or all similar entities should
be mapped to a common terminology (e.g., drugbank:BE0000048 ←−−→
x−re f
hgnc:3535 ←−−→
x−re f
kegg:HSA_2147, where the
different URIs for protein PROTHROMBIN are mapped to the Hugo Gene Nomenclature Committee (HGNC) identifier) using
such x-ref attributes from popular RDFS vocabularies29.
Ideally, in the case of RDF datasets, the terminological T -Box elements (i.e., classes and properties used in the schemas)
should be reused from existing OWL ontologies or RDFS vocabularies. Large repositories of existing RDFS vocabularies are
developed, either curated manually (e.g., Linked Open Vocabularies35) or by exploring the LSLOD cloud through automated
crawlers. These repositories can serve as sources for data publishers to reuse elements from existing vocabularies. Moreover, in
biomedicine, the classes from existing biomedical ontologies in the BioPortal repository36 can also be reused when publishing
LD. RDF instances in the assertional A-Box may also be linked to classes from OWL ontologies using equivalence properties,
such as x-ref or owl:sameAs as shown in Figure 1D. However, cases where RDF ‘instances’ are mapped to ‘classes’ in other
ontologies or LD graphs using equivalence properties are often designated as semantic mismatch cases.
In some cases, the same relation may be expressed in different RDF graphs using different semantics or graph patterns13.
For example, the same attribute of molecular weight is expressed in two different LD sources, DrugBank and KEGG, using
drugbank:molecular-weight and kegg:mol_weight respectively. Ideally, the molecular weight attribute assertions should
be structured using a uniform property across different sources. This property can originate from any of the LOV vocabularies or
biomedical ontologies (e.g. CHEMINF:000216 “average molecular weight descriptor” from the Chemical Information Ontology).
However, in the current state of the LSLOD cloud, a user who wishes to retrieve and reconcile such relations from multiple
linked data graphs must be aware of the underlying semantics and the data model used in these graphs.
There are several benefits for reuse or cross-linking between similar entities or classes in different linked data graphs or
ontologies29, 37 — i) reduction in data and knowledge engineering costs since the publisher can reuse existing minted URIs or
link to existing entity descriptions, ii) enabling semantic interoperability among different datasets and applications, and iii)
querying multiple linked data graphs simultaneously using federated architectures. The lack of reuse or cross-linking as well as
the use of different semantics or graph patterns for modeling data in a given linked data graph leads to an increase of semantic
heterogeneity across the LSLOD cloud.
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Related Research
Previously, we had conducted a similar study to estimate term reuse (i.e., reuse of classes from existing ontologies) and term
overlap (i.e., similar classes across ontologies which are not reused) across biomedical ontologies stored in the BioPortal
repository37. We found that ontology developers seldom reuse content from existing biomedical ontologies. However, there is
significant overlap across the BioPortal ontologies. The concepts of term reuse and term overlap also hold true in the context of
linked data (LD) sources. However, in the biomedical domain, there are several critical differences between ontologies and
LD sources due to the manner through which these sources are created and formalized. Some of these differences include: i)
the vocabularies and schema for biomedical LD sources are significantly smaller compared to most biomedical ontologies, ii)
LD sources have a much higher number of instances compared to biomedical ontologies and these instances may be reused
from external resources, iii) LD vocabularies formalized using the RDFS language may have less rich annotations compared to
OWL ontologies (e.g., lack of synonyms and alternate labels), and iv) LD sources, formalized using RDF and RDFS, may
use reification to capture information at a higher granularity. Hence, the methods to analyze semantic heterogeneity across
biomedical ontologies cannot be translated “as is” to analyze semantic heterogeneity across biomedical linked data sources.
A recent study found that the coverage of biomedical ontologies and public vocabularies is not sufficient to structure the
entirety of biomedical linked data38. Hence, linked data publishers end up creating their own custom vocabularies, and do
not publish them in a standardized way for reuse in other projects. Recently, multiple studies have been conducted on the
larger Linked Open Data cloud to investigate the availability and licensing of Semantic Web resources, as well as to provide
a mechanistic definition of what constitutes a ‘link’ in open knowledge graphs available on the Web39–41. However, these
studies do not particularly focus on the semantic heterogeneity and vocabulary reuse across the Life Sciences Linked Open
Data cloud42
We use an Extraction Algorithm to extract and merge the schemas and vocabularies used by biomedical linked data sources
for conducting our meta-analysis. The theory behind the Extraction Algorithm has identical characteristics to linked data
profiling algorithms43–46. However, the linked data profiling algorithms have, in many cases, only been implemented over some
of the popular SPARQL endpoints, do not account for variable SPARQL versions, require the retrieval of all instances and
assertions that is often not scalable for LSLOD sources, or may not extend behind minimal schema extraction. Similarly, RDF
graph pattern mining algorithms (e.g., evolutionary algorithms47) often require exhaustive training samples of (source, target)
pairs which are often not possible to obtain for the LSLOD cloud.
Datasets
In the subsequent sections, we will provide you with details on the linked data graphs which were extracted from SPARQL
endpoints exposed on the Life Sciences Linked Open Data (LSLOD) cloud. We also present details on additional corpora and
datasets used as background knowledge sources to conduct our meta-analysis on the semantic heterogeneity across the linked
data graphs.
Linked Data Graphs
We extracted the schemas and vocabularies used in the RDF graphs exposed through ≈ 20 SPARQL endpoints by different
consortia. The entire list of the different linked data projects and details about sample RDF Graphs extracted are shown in
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Linked Data Project Example RDF Graphs and Descriptions
Bio2RDF33 Several reprocessed data and knowledge sources such as:
DrugBank11 — Drug and drug target information
KEGG9 — Biological pathways, proteins, and drugs
PharmGKB48 — Protein–drug–disease relations
CTD49 — Environmental chemical–protein interactions and
pathway–disease relations
EBI-RDF50 Several proprietary data and knowledge sources such as:
Reactome8 — Biochemical reactions and pathways
BioSamples51 — Metadata about biological samples
ChEMBL52 — Drug-like molecules and activities
UniProt7 UniProt database on proteins and their characteristics
MO-LD53 Model Organism databases on different species such as Fly, Mouse,
Yeast, Rat, Human and Zebrafish
NBDC RDF54 Japanese Life Sciences databases on chemicals, structures, sequenc-
ing data, pathways, and diseases
Linked Life Data55 Several reprocessed data and knowledge sources such as:
EntrezGene31 — Genes and variants in diseases
BioGrid56 — Protein and chemical interactions
IntAct57 — Protein–protein interactions
Linked TCGA27 DNA methylation, gene expression and clinical data of cancer pa-
tients from The Cancer Genome Atlas3
NIH PubChem5 Databases on substances, compounds, structures, and biological as-
says stored in the PubChem repository
WikiPathways58 Database of biological pathways maintained using a crowd-sourcing
architecture
PathwayCommons59 Data warehouse consisting of several biological pathways and molec-
ular interactions datasets
NLM MeSH60 Medical Subject Headings used to index biomedical publications in
MEDLINE repository61
DisGenet62 Data warehouse on genes and variants associated to diseases
NextProt63 Data warehouse on protein structures and interactions
LinkedSPL64 Structured product labels of drugs represented as RDF
Table 1. Linked data sources queried to generate the GLSLOD schema graph of the LSLOD cloud.
Table 1. These RDF graphs include popular biomedical data sources such as DrugBank11, Kyoto Encyclopedia of Genes and
Genomes (KEGG)9, PharmGKB48, Comparative Toxicogenomics Database (CTD)49, exposed by the Bio2RDF consortium33,
UniProt7, ChEMBL52, and Reactome8, exposed by the EBI-RDF consortium50, and other sources such as The Cancer Genome
Atlas (TCGA)3, PubChem5, and WikiPathways58. It should be noted that some of these projects (e.g., Bio2RDF33) have
reprocessed publicly available data and knowledge published by other groups (e.g., DrugBank11), whereas in some cases
data publishers themselves use Semantic Web technologies to provide access to their proprietary data as linked data (e.g., the
European Bioinformatics Institute (EBI) RDF Platform50).
These RDF graphs contain data and information on several biomedical entities such as drugs, genes, proteins, pathways,
diseases, protein–protein interactions, drug–protein interactions, biological assays, and high-throughput sequencing. This is the
largest collection of biomedical linked data sources that have functioning SPARQL endpoints or RDF dumps available on the
Web. The endpoint URLs for these projects are listed at http://onto-apps.stanford.edu/lslodminer.
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Corpus of Biomedical Ontologies
We obtained a dump of 685 distinct biomedical ontologies stored in the BioPortal repository,3 the world’s largest open repository
of biomedical ontologies36. These ontologies were serialized using the N-triples format and versioned up to January 1, 2018.
This dump did not contain some ontologies that were deprecated or merged with existing ontologies, or added to BioPortal
after January 1, 2018. This corpus includes widely used ontologies such as Gene Ontology (GO)28, National Cancer Institute
Thesaurus (NCIT)65, Chemical Entities of Biological Interest (ChEBI) Ontology6, and Systematized Nomenclature of Medicine
- Clinical Terms (SNOMED CT)66, which are widely used in biomedicine for data annotation, knowledge management, and
clinical decision support.
Corpus of Linked Open Vocabularies
Linked Open Vocabularies4 (LOV) is a catalog of RDFS vocabularies available for reuse with the aim of describing data on the
Web35. This catalog consists of standardized versions of general RDFS vocabularies that are often used to encode additional
semantics for RDF graphs on the LSLOD cloud. Popular examples of vocabularies in this catalog include the W3C Provenance
Interchange67, Simple Knowledge Organization System (SKOS)68, and Schema.org69. We used 647 vocabularies that were
present in the LOV catalog, as of January 1, 2018. The vocabularies in this catalog generally include concept descriptions (i.e.,
human-readable labels using the rdfs:label annotation properties).
Word Embedding Vectors Generated from the MEDLINE Corpus
We generated 100-dimensional word embedding vectors from a corpus of approximately 30 million biomedical abstracts, stored
in the MEDLINE repository61, using the GloVe (Global Vectors for Word Representation) method70. The steps taken to process
biomedical abstracts (tokenization, medical entity normalization, etc.) were performed in accordance with those outlined in
Percha, et al.19. Word embeddings represent words as high-dimensional numerical vectors based on co-occurrence counts of
those words as observed in the abstracts. These embedding vectors are available under a CC BY 4.0 license at FigShare,5 and
have been used to map metadata fields in the BioSamples repository51 to ontology terms in the BioPortal repository71, as well
as to identify biomedical relations in unstructured text16.
Methods
The meta-analysis conducted over the Life Sciences Linked Open Data (LSLOD) cloud relies on a set of extractors which
navigate to each SPARQL endpoint that is available on the Web and that extract the schemas and vocabularies from those
SPARQL endpoints. We have downloaded and stored RDF dumps in local SPARQL repositories to handle cases where an
LSLOD source does not have a functional SPARQL endpoint but is available as an RDF data dump. The extractors use an
Extraction Algorithm, whose technical underpinnings are provided in Supplementary Material.
Extraction Algorithm
The Extraction Algorithm uses a set of SPARQL query templates (listed in Supplementary Material) to extract schemas (e.g.,
classes, properties, domains, ranges) as well as sample instances of those classes and their property values from the SPARQL
3https://bioportal.bioontology.org/
4https://lov.linkeddata.es/dataset/lov/
5https://figshare.com/articles/Biomedical_Word_Vectors/9598760.
9/32
Figure 2. Diagrammatic Representation of the Extraction Algorithm. During the extraction phase, automated extractors
(represented as black spiders here) query each SPARQL endpoint in the LSLOD cloud and extract the schemas (i.e., classes,
object properties, data properties, URI patterns, graph patterns) to generate the LSLOD Schema Graph GLSLOD. A portion of
GLSLOD is visualized here, using a force-directed network, with classes (purple nodes), object properties (green nodes) and data
properties (orange nodes) extracted from multiple sources, such as Bio2RDF, EBI-RDF, etc.
endpoints in the LSLOD cloud. The input to the Extraction Algorithm is the SPARQL endpoint, whose version of SPARQL can
be automatically detected based on the SPARQL queries and keywords supported. The Extraction algorithm not only accounts
for different versions of SPARQL supported at the remote SPARQL endpoints, but also uses alternative SPARQL queries if the
remote endpoint times out during the extraction phase.
An extractor that encapsulates the Extraction Algorithm selects the set of SPARQL query templates for execution against the
input SPARQL endpoint, given its version. The extractor queries the SPARQL endpoint and extracts the RDF graphs exposed
through the SPARQL endpoint. For each RDF graph, the extractor extracts the set of classes and the total number of instances
for each class. The extractor identifies the properties for which a specific class serves as the domain for all assertions, and also
retrieves the range classes for object properties, or the datatypes for data properties. The Extraction Algorithm also extracts
a random sample (without replacement) of 2,000 instances for each class and 2,000 property assertions for a class–property
combination, and generates summary characteristics (e.g., categorical, datatype, namespace, median length, regular expression
patterns) of the associated data.
Classes, properties, and datatypes, are represented as nodes in the schema graph GT −Box extracted from the SPARQL
endpoint by the specific extractor. The edges link property nodes to class nodes and datatype nodes depending on the domain and
range descriptions of the corresponding property. The nodes and edges are annotated by the count and summary characteristics
of corresponding instances or property assertions respectively. This schema graph is a fragment of the actual T -Box of the
RDF graph. The GT −Box graphs extracted for all RDF graphs in the LSLOD cloud are merged to generate the schema graph
GLSLOD of the entire LSLOD cloud. A diagrammatic representation of this method and a subset of the merged GLSLOD schema
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graph are shown in Figure 2.
The Extraction Algorithm and the SPARQL query templates used by the algorithm are documented in Supplementary
Material in greater technical detail.
Determining Vocabulary Reuse across Biomedical Linked Data Sources
Estimating the extent of observed vocabulary reuse across different biomedical linked data sources requires identifying the
classes and properties most commonly reused from standard ontologies and vocabularies. We use the corpus of biomedical
ontologies stored in the BioPortal repository36 as well as popular RDFS vocabularies published on the Linked Open Vocabularies
repository35 for this goal. We also use the GLSLOD schema graph extracted from the LSLOD cloud.
For each URI in the GLSLOD schema graph (class, property, or sample instance URI), the origin of the URI is determined
using a heuristic approach72 by converting each URI to lowercase and using regular expression filters constructed from
namespaces (e.g. ncicb.nci.nih.gov for NCIT65) and common identifier patterns.
For each linked data source, we compute the following statistics:
1. The number of ontologies and vocabularies reused in the source
2. The percentage of schema elements reused from external LSLOD sources
3. The percentage and distribution of classes whose entities are mapped or linked to other entities in external LSLOD
sources (interlinking)
4. The percentage and distribution of classes whose entities are mapped or linked to entities of other classes in the same
LSLOD source (intralinking)
5. The percentage of entities reused or mapped to external LSLOD sources
Previously, we outlined a method to estimate reuse of classes across multiple biomedical ontologies37. We repurposed this
method to estimate vocabulary reuse across biomedical linked data sources. We generated an undirected network composed of
different URIs from the GLSLOD schema graph as nodes (i.e., the classes and the properties), and the edges indicating reuse and
mapping between the different schema element URIs. “Patterns” of instance URIs are also represented as nodes in this network
to check if instances are reused or mapped to classes in biomedical ontologies (i.e., semantic mismatch). We extract connected
components from this network and use Equation 1 to estimate vocabulary reuse.
Vocabulary Reuse =
∑ j|Tj∈Mr n j− k
N
(1)
In the above equation, assume that the network is composed of k connected components {T0,T1, . . . ,Tk}, and each
component T j is formed from n j schema elements (i.e., {t0 j, t1 j, . . . , tn j} ∈ T j). Assume that N is the total number of schema
element URIs in the network. The number of terms in a component Tj must follow 1 < n j < N (i.e., components with a single
term are not allowed). All schema elements in one component exhibit some reuse with respect to each other.
Detecting Communities of Related Content in the LSLOD Cloud
To detect clusters of related content in the LSLOD cloud, we used a 5-step algorithm that maps similar schema elements (e.g.,
classes and properties) between two different sources in the LSLOD cloud. A diagrammatic representation of this algorithm is
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Figure 3. Diagrammatic representation of the Algorithm to Detect Communities of Similar Content across LSLOD
Cloud: The labels for two URIs are extracted either i) by matching to a reused ontology, or ii) by using annotation properties
such as rdfs:label or skos:prefLabel, or iii) by using regular expressions on the URI. URI embeddings are generated from the
extracted labels, by using a background source of MEDLINE biomedical abstracts. A similarity network is created with nodes
representing the different URIs from the GLSLOD schema graph and edges representing the cosine similarity scores between two
URI embeddings. We detect communities in this network using the Louvain method. The trivial example shown here is related
to similar “molecular weight” URIs between the Model Organism - linked data (MO-LD) project and the Bio2RDF KEGG
linked data graph.
shown in Figure 3. This algorithm uses the schema elements extracted from the various LSLOD public SPARQL endpoints
(see 1) and included in the GLSLOD graph. These schema elements may or may not be reused from a common vocabulary
or ontology (vocabulary reuse in LSLOD cloud was determined using the methods described in the previous section). The
algorithm uses two sources of background knowledge to generate the mappings between two different schema elements: i)
word embeddings generated from the MEDLINE corpus, and ii) the set of biomedical ontologies and vocabularies that are
reused across biomedical LD sources.
Label Extraction
In the first sweep, the algorithm extracts a label for each schema element URI (i.e., class, object property or data property) in
the GLSLOD graph. This is done through three approaches in a sequential flow:
1. A label is extracted from the values for the rdfs:label22 or skos:prefLabel68 annotation properties, if the GLSLOD
schema element has already been reused from existing biomedical ontologies and vocabularies (see Datasets).
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2. A label is extracted by querying the source (i.e., the SPARQL endpoint) of the schema element for rdfs:label or
skos:prefLabel annotation assertions.
3. A label is generated using Regular Expression (RegExp) filters from the URI of the schema element. Specifically, the
filters deal with cases where separators (e.g., "-", "_") and camel case (e.g. hasMolecularWeight) is present in the URI. In
Figure 3, the labels “Has Molecular Weight” and “Mol Weight” will be extracted from the two URIs respectively.
URI Embedding Generation
Each schema element URI is then represented in a high dimensional space using word embedding vectors. Specifically, a
vocabulary of words6 is generated from 30 million PubMed biomedical publication abstracts. A URI embedding vector is
generated by computing a weighted average of the embedding vectors of the words in the URI label, with the weights being
the Inverse-Document-Frequency (IDF) statistic for each word. A default embedding vector and IDF statistic is created for
any word that is not present in the vocabulary. The equation to generate a URI embedding vector is shown below. Here, x(wi)
represents the 100-dimensional word embedding vector, and L(URI) is the URI label.
x(URI) =
∑wi∈L(URI) id f(wi) ∗x(wi)
∑wi∈L(URI) id f(wi)
(2)
Cosine Similarity Score Computation
For any two schema element URIs that are not present in the same source, cosine similarity scores are computed using their
URI embedding vectors. The equation to compute the similarity between two elements is presented below.
Sim(A,B) =
x(URIA) ·x(URIB)
||x(URIA)||||x(URIB)||
=
∑n=100i=1 x(URIA)i ∗ x(URIB)i√
∑n=100i=1 x2(URIA)i
√
∑n=100i=1 x2(URIB)i
(3)
Creating a Similarity Network
A similarity network is created where the different schema element URIs represent the nodes of this network. An edge exists
between two nodes if: i) the cosine similarity score between the corresponding URIs is greater than the threshold of 0.75, and
ii) there exists a one-to-one mapping between the two schema elements for the particular combination of linked data sources.
For example, consider three URI nodes n1,n2,n3, such that, n1,n2 ∈LD1 and n3 ∈LD2. If Sim(n1,n3)= 0.87,Sim(n2,n3)=
0.93 then an edge will only be created between n2 and n3 nodes. This criteria has an underlying assumption that there should
exist a unique alignment between similar schema elements in different linked data sources. While the cosine similarity scores in
the previous step can, by itself, aid in detection of similar schema elements (e.g., all schema elements pertaining to Molecular
weight), this similarity network will aid in the detection of sources that contain relevant information pertaining to a given
biomedical concept or relation type.
Community Detection using Louvain Method
Finally, the Louvain method73 for community detection in weighted networks is used. The cosine similarity scores form the
edge weights in the similarity network. This method has been used to detect communities of users using social networks and
mobile phone usage data, as well as detect species in network-based dynamic models74–76. The Louvain method maximizes a
6A word should appear in at least five separate abstracts for inclusion in the vocabulary.
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‘modularity’ statistic Q, which measures the density of edges inside communities compared to edges between communities. In
the equation below (reproduced from Blondel, et al.73), 2m is the sum of all edge weights in the graph (i.e., m = 12 ∑i j Sim(i, j))
and ki is the sum of all weights to edges attached to node i (i.e. ki = ∑ j Sim(i, j)). δ (ci,c j) is a delta function that looks at the
community assignments (ci and c j) for connected nodes i and j.
Q =
1
2m∑i j
[
Sim(i, j)− kik j
2m
]
δ (ci,c j) (4)
δ (ci,c j) =
 1 if (ci = c j)0 if (ci 6= c j) (5)
The communities are visualized using the Cytoscape platform77.
Results
LSLOD Schema Graph GLSLOD
Using the Extraction Algorithm, we extracted 99 RDF Graphs7 from ≈ 20 SPARQL endpoints. The total number of classes,
object properties, data properties, and datatypes extracted and linked in the GLSLOD schema graph were 57,748, 4,397, 8,447
and 24 respectively. The extractors can function on any SPARQL endpoint irrespective of its i) version, ii) support for different
SPARQL keywords25, and iii) the size of the underlying RDF graphs. The Extraction Algorithm can generally process most
SPARQL endpoints within 4–8 hours. A visualization of a portion of the extracted GLSLOD schema graph is shown in Figure
2B. A snippet of the extracted information for a given source is shown in Listing 1.
Through an empirical analysis, we have found some overlap between the different schema elements, based on the way
linked data publishers model the underlying data (i.e., some object properties in a given source are used as data properties in
another linked data source). We found standard datatypes defined under the XML Schema Definition (XSD)78 and RDFS22
such as xsd:string, xsd:integer, xsd:float, xsd:dateTime, xsd:boolean, rdfs:Literal. The analysis also found an
ontology class UO:0000034 (Units Ontology79 WEEK class) used as a datatype. In some cases, we also found that RDF graphs
may exhibit Semantic Mismatch where instances are aligned to classes from an exhaustive ontology, such as ChEBI6 or NCIT65
that have more than 50,000 classes, using the rdf:type property. Semantic Mismatch in linked data is a form of semantic
heterogeneity. Since rdf:type is a predicate in almost all the SPARQL query templates used by the Extraction Algorithm,
semantic mismatch significantly increases the number of classes in the GT −Box, and consequently the number of queries that
need to be formulated for each class significantly increases (See Supplementary Material).
Vocabulary Reuse across Linked Data Sources
We analyzed the 70,592 total schema elements (classes, object properties, and data properties) extracted from the linked data
sources in GLSLOD for vocabulary reuse. In this research, we looked only at reuse of schema elements from vocabularies
published at the Linked Open Vocabularies (LOV) repository35 and ontologies that are either published at the BioPortal
repository36 or on the Web as OWL files available for download (and have .owl in the namespace prefix, for easy search).
7This number varies since a database may divided into multiple graphs with different URIs to be stored in a SPARQL endpoint. We have merged similar
RDF graph URIs based on the actual data source.
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Source: DrugBank
Source URI: http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3
Classes:
Class: Drug
Class URI: http://bio2rdf.org/drugbank_vocabulary:Drug
Sample Instances: [’http://bio2rdf.org/drugbank:DB03536’, ...]
Class: Drug-Drug-Interaction
Class URI: http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction
...
Properties:
Object Property: target
Property URI: http://bio2rdf.org/drugbank_vocabulary:target
Property Realization: drugbank:Drug -> drugbank:target
Domain: Drug, Range: Target
Sample Assertion Values: [’http://bio2rdf.org/drugbank:BE0000059’, ...]
Data Property: molecular-weight
Property URI: http://bio2rdf.org/drugbank_vocabulary:molecular-weight
Property Realization: drugbank:Enzyme -> drugbank:molecular-weight
Domain: Enzyme, Range: Float
Sample Assertion Values: [52221.099999999999, 56345.0, 57530.0, ...]
Listing 1. Information from the Bio2RDF DrugBank RDF Graph extracted by the Extraction Algorithm
Figure 4 shows the results of the analyses. Figure 4a depicts a histogram of schema elements that are shared across X
number of linked data sources. It can be observed that most LD sources are composed of unique schema elements that are
present only in that particular source (i.e., the first histogram bar from the left). However, there are at least > 100 schema
elements that are shared between > 10 LD sources (i.e., the last four histograms from the right).
Terms are reused in biomedical linked data graphs from 34 BioPortal ontologies, 7 other biomedical ontologies, available
on the Web but not stored in the BioPortal repository, and 43 LOV vocabularies (Figure 4b). Some of the reused ontologies and
vocabularies are very popular in biomedicine (e.g., ChEBI6, SNOMED CT66, NCIT — National Cancer Institute Thesaurus65,
GO — Gene Ontology28) and in the Semantic Web community (e.g., DCTerms Metadata Description Model80, RDFS22, SKOS
— Simple Knowledge Organization System68, Data Catalog Vocabulary81) respectively.
However, most of these biomedical ontologies are used only in the schemas of a few LD sources (X-axis), and moreover only
a few elements from these ontologies are reused (Y-axis). For example, the Anatomical Therapeutic Chemical Classification
terminology82 — popularly used to classify drugs according to their mechanism of action — is used in the schema of only one
LD source. It can be seen that several LD sources use unpublished schemas (green diamonds), hence, a large number of unique
schema elements are present in only one source in Figure 4a.
Several LD sources do reuse schema elements from a set of widely used vocabularies (≈ 100 as per Figure 4a). However,
the elements of these vocabularies are not useful for data integration and integrated querying from a biomedicine perspective.
It should be noted that several elements from the combination of the Semantic Science Ontology and Chemical Information
Ontology (SIO-CHEMINF)83 are reused across several LD sources and may be a popular resource for the emergence of a
common data model for integrated querying of these sources8.
Using Equation 1, vocabulary reuse was determined to be 19.86%, which may indicate favorable reuse across LD sources
8A large number of these LD sources however only use one particular element from SIO ontology.
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Figure 4. Vocabulary reuse across biomedical linked data sources (RDF graphs): a) A histogram of schema elements
that are shared across multiple LD Sources. It can be seen that most LD Sources use a unique schema or vocabulary whose
elements are not reused across any other data source. However, there are at least 100 schema elements that are shared by > 10
LD Sources. b) The different vocabularies (published at LOV repository) and ontologies (BioPortal and other OWL ontologies)
whose elements are reused in the schemas of LD sources. Several LD sources either use unpublished schemas or use elements
from common vocabularies (e.g. DCTerms and SKOS).
in comparison to ontologies. However, it should be noted that this statistic may be driven by the reuse of 30,251 ChEBI classes
in a few sources. We also determined several cases of semantic mismatch where classes from popular biomedical ontologies in
the BioPortal repository (e.g., SNOMED CT, NCIT, GO) are mapped to instances in these LD sources.
Figure 5 shows the different RDF graphs extracted as nodes in a network. The size of the node indicates the number of
unique object properties used to link entities in different classes from the same source (Intra-Linking). The size of the edge
connecting two different nodes indicates the number of unique object properties used to link entities in different classes in
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Figure 5. Interlinking and intra-linking across biomedical linked data sources (RDF graphs). Each unique RDF Graph
retrieved by the Extraction Algorithm is shown as a node in this network. The size of the node indicates the number of unique
object properties used to link entities in different classes from the same source. The size of the edge indicates the number of
unique object properties used to link entities in different classes in different sources.
different sources or RDF Graphs (represented using the corresponding node). This network diagram can be perceived to be
similar to the LSLOD cloud diagram9. It can be observed that the LSLOD cloud is not actually as densely connected as is
often indicated through the LSLOD cloud diagram. Several sources, which may exhibit a higher degree of intra-linking are not
inter-linked with other RDF graphs and exist as stand-alone data sources converted using RDF. The highly appreciated efforts
by the Bio2RDF33 and EBI-RDF50 consortia can be seen in the dense interlinking between the consortia-published sources.
Communities of Related Content in the LSLOD Cloud
While the low level of vocabulary reuse across linked data sources present a bleak picture of the Semantic Web vision toward
facilitating Web-scale computation and integrated querying, it should be noted that there is significant similarity of content
across these sources.
We generated 100-dimensional word embedding vectors and inverse document frequency (IDF) statistics for a vocabulary
of 2,531,989 words from approximately 30 million MEDLINE biomedical publication abstracts. Using these word embedding
vectors and IDF statistics, we generated 100-dimensional URI embedding vectors for different schema elements URIs in
the GLSLOD schema graph. Whereas the word tokens for most URI labels were found in the vocabulary, 3,340 word tokens,
9http://lod-cloud.net
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such as ‘differn’, ‘heteronucl’, and ‘neoplas’ were not found either due to typos or due to minimal occurrence frequency in
publications. We represented these words using the default embedding vector and IDF statistic. We computed cosine similarity
scores to detect additional mappings between different schema elements. For example, the drugbank:Molecular-Weight
class has higher cosine similarity scores to related schema elements, such as kegg:mol_weight, biopax:molecularWeight,
and MOLD:hasMolecularWeight data properties, as well as the CHEMINF:000198 (MOLECULAR WEIGHT CALCULATED BY
PIPELINE PILOT) class.
A similarity network was created with 12,613 schema elements as nodes in this network. This number of nodes is less than
the total number of schema elements in the GLSLOD schema graph (70,587). We excluded domain-specific classes that were
reused from ChEBI and other ontologies through semantic mismatch. We also excluded URIs for which labels could not be
extracted.
Edges were created between these nodes using the cosine similarity scores between the corresponding schema ele-
ments. There were 169,005 pairs of schema element URIs that satisfied the first criterion of having a cosine similarity
value above the threshold of 0.75. This threshold was predetermined after an exploratory analysis of pairs of schema
elements that satisfied this criterion. While it would make sense to have a higher threshold (≈ 0.95) for a higher de-
gree of certainty on similarity, having a threshold of 0.75 allowed the inclusion of pairs, such as obo:regulates ↔
drugbank:mechanism-of-action: 0.75, chembl:mechanismDescription ↔ drugbank:mechanism-of-action: 0.85,
faldo:location↔ drugbank:cellular-location: 0.89. After applying the second criterion of one-to-one mapping be-
tween two schema elements for a particular combination of linked data sources, the network had 22,855 pairs of schema-element
URIs for which edges were created.
We used the Louvain method for detecting communities in the weighted similarity network. The method terminated
after achieving a maximum modularity statistic (i.e., the density of edges inside communities compared to edges between
communities) of 0.817296. We detected 6,641 communities. While most of these communities had minimal membership (i.e.,
≤ 10 schema elements were members), there were 51 communities with more than 10 schema elements as members. On visual
inspection using the Cytoscape network visualization platform, we determined that these communities primarily consisted of
schema elements related to a few key biomedical concepts or relation types. These communities are partially visualized in
Figure 3, with two communities composed of schema elements related to ENZYME and PHENOTYPE concepts visualized in a
greater detail in Figure 6. ENZYME entities are specialized proteins which act as biological catalysts to accelerate biochemical
reactions, whereas PHENOTYPE entities are composite observable characteristics or traits of an organism.
In Figure 6, each node is a distinct schema element URI (i.e., class, object property or data property) observed in the
GLSLOD LSLOD schema graph. These nodes are colored based on the linked data project they are primarily present in (e.g.,
Bio2RDF, EBI-RDF). It should be noted that each linked data project (e.g., Bio2RDF) may publish multiple sources as distinct
RDF graphs (e.g., KEGG9, DrugBank11). The shape of the nodes is reminiscent of the type of schema element — classes are
represented as rectangular nodes, object properties as elliptical nodes, and data properties as diamond nodes. The nodes are
labeled using the extracted labels, but the underlying URIs may be completely different. The width of the edge connecting
different nodes is proportional to the cosine similarity scores between the URI embeddings of the connected schema elements.
It can easily be seen that different schema element URIs may be used across different sources (even if the sources are
published by the same linked data project) to model and represent similar content and information (e.g., information on enzymes
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Figure 6. Communities of Similar Content across Biomedical Linked Data. Two communities composed of schema
elements related to ENZYME and PHENOTYPE concepts are visualized in a greater detail. The nodes indicate a distinct schema
element (distinct URI), and are colored according to the linked data project they are present in. The shape of the nodes
indicates the type of schema element (class, object property, data property). The width of an edge between two nodes is
proportional to the cosine similarity score between the URI embeddings of the corresponding schema element. Smaller
sub-communities related to REACTION, Enzyme Commission Number and OMIM Phenotype Identifier (Online Mendelian
Inheritance in Man) are also observed.
or phenotypes). It also showcases that data and knowledge relevant to a particular biomedical entity may be scattered across
multiple sources (i.e., knowledge on a particular ENZYME entity can be retrieved from Bio2RDF, EBI-RDF and NextProt,
and in many cases this knowledge may be novel). Other communities composed of schema elements focused on other key
biomedical concept or relation types are also observed (e.g., DRUG, PUBLICATION, CHROMOSOME). The primary composition
of a few of these larger communities (> 30 members) is listed in Table 2. It should be noted that these communities may
be composed of multiple sub-communities. For example, a sub-community of schema elements related to the REACTION
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concept is linked to the main cluster of nodes related to the ENZYME concept, since ENZYME entities are often associated with
REACTION entities.
Smaller communities (< 10 members) also consist of specific schema elements in different sources that are similar to each
other but that are in label mismatch through use of different URIs (e.g., SNORNA is represented using
MOLD:yeastmine_SnoRNAGene, MOLD:humanmine_SnoRNA, EBIRDF:ensembl/snoRNA,
BIO2RDF:ncbigene_vocabulary/SnoRNA-Gene, NBDC:mbgd#snoRNA). Knowledge of such communities will aid biomedical
researchers to determine which sources in the LSLOD cloud contain information relevant to their domain of interest (e.g.,
research on small nucleolar RNAs SNORNA, a class of small RNA molecules that primarily guide chemical modifications).
Discussion
Semantic heterogeneity across different data and knowledge sources, either in the use of varying schemas or entity notations,
severely hinders the retrieval and integration of relevant data and knowledge for use in downstream biomedical applications (e.g.,
drug discovery, pharmacovigilance, question answering). Enhancing the quality and decreasing the heterogeneity of biomedical
data and knowledge sources will lead to enhanced inter-disciplinary biomedical research, which will lead to developing better
clinical outcomes and increasing our knowledge on biological mechanisms.
So far, significant resources have been invested to represent, publish, and link biomedical data and knowledge on the
Web using Semantic Web technologies to create the Life Sciences Linked Open Data (LSLOD) cloud. However, there are
very few biomedical applications that query and use multiple linked data sources and biomedical ontologies directly on the
Web to generate new insights, or to discover novel implicit associations serendipitously. This is, in part, due to the semantic
heterogeneity emanating from underlying sources, which has also penetrated the LSLOD cloud in varying forms. Some of
the primary benefits of the LSLOD cloud — querying, retrieval, and integration of heterogeneous data and knowledge from
multiple sources on the Web seamlessly — cannot be availed.
Linked data publishers are strongly encouraged to reuse existing models and vocabularies and to provide links to other
sources in the LSLOD cloud29, 84. Similarly, biomedical ontology developers are strongly encouraged to reuse equivalent
classes existing in other ontologies, while building new ontologies85, 86. There are several benefits if biomedical ontologies
and linked data sources reuse content from existing sources — i) reduction in data and knowledge engineering and publishing
costs, ii) decrease in semantic heterogeneity and increase in semantic interoperability across datasets, and iii) ease of querying,
retrieval, and integration of data from multiple sources simultaneously through existing query federation methods37. On the
other hand, lack of reuse will manifest as increased semantic heterogeneity across different LSLOD sources.
It can be asserted through the findings presented in this research that the Life Sciences “Linked” Open Data cloud is
not actually as densely connected as is often indicated through the ubiquitously-referenced LSLOD cloud diagram. Several
sources, which may exhibit a higher degree of intra-linking are not inter-linked with other RDF graphs and exist as stand-alone
data sources converted using RDF (Figure 5). Similarly, Figure 4 shows that several biomedical linked data sources use
unpublished schemas. Biomedical linked data sources do reuse schema elements from a set of popular vocabularies. However,
these vocabularies originate from the Semantic Web community (e.g., those that are mainly used to refer to data elements
and attributes) rather than from the biomedical community (e.g., those that are used to provide normalization schemes for
biomedical entities). Hence, the elements of these vocabularies are not useful for data integration and integrated querying from
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Com. Total Key Biomedical Concepts
Id. Elements
5023 549 Clinical (Age, Treatment, Summary, Dosage, Diagnosis)
Cancer (Stage, Tumor, Cell, Sample, Rate)
Genomics (Experiment, Target, Function, Interaction, Correlation, As-
sembly, Association, Expression, Genetic)
3098 281 Protein and Genomic Sequences (Sequence, Position, Start, Length,
Protein, End, Repeat, Gene, Match, Begin, Translation, Exact, Exon,
Frame, Distance)
2842 271 Clinical (Date, Condition, Entry, Process, Person, Diagnosis, Participant,
Outcome, Indication, Therapy, Evidence, Access)
4346 260 Data (Code, Reference, Database, Sample, Data, Ontology, Semantic,
Experiment, Dataset, Assembly, Registry)
2879 231 Clinical (Clinical, Group, ICD)
Genetic (Gene, Entity, Ncbigene, Species, Atom, Ref)
3945 228 Biomedical Relations (Disease, Relationship, Expression, Gene, Level,
Sample, Drug, Interaction, Component)
2515 211 Protein (Protein, Site, Region, Molecule, Domain, Binding, Interaction,
Active, Atom, Canonical, Primary, Structure)
6376 210 Literature (Description, Author, Entity, Details, Note, Article, Issue,
List, Type, Study, Entry, Document, Data, Address)
1417 192 Identifiers (Uniprot, Identifier, Accession, Ensembl, Taxonomy, PDB,
Genbank, Gene, MGI, Database, Id, Refseq, NCBI, CDS)
1632 171 Identifiers (Id, Taxon, Mesh, Entity, Type)
Genomics (Platform, Entry, Sample, Genus, Array, Gene, List)
3249 171 Genotype–Phenotype Associations (Gene, Symbol, Association, Prod-
uct, Variant, Tag, Locus, Phenotype, Allele, Disease)
5652 158 Genomics (RNA, Probe, Strand, Direction, Region, DNA)
1446 132 Software (Version, Software, File, Format, Image, Email, Scale)
2535 126 Drug (Drug, Chemical, Action, Ingredient, Bond, Activity)
2421 110 Chromosome (Location, Chromosome, Entity, Cellular)
2317 105 Pathway (Pathway, Molecular, Formula)
Unit (Weight, Body, Units, Volume, Unit)
1806 101 Source (Source, Natural, Vector, Derived, Tissue)
2672 99 Literature (Count, Text, Comment, Editor, List, Data, Notes)
6316 97 Ontology (Annotation, Ontology, Type, Structure)
5969 83 Social (Status, Gender, Authority, Interaction)
2429 79 mRNA (Transcript, mRNA, Signal, Frequency, Expression)
1868 77 Literature (Citation, Publication, Journal, Literature)
1349 67 Assay (Method, Assay, Type, Measurement)
6241 62 Genetic (Strain, Allele, Mutation, Genotype, SNP)
6052* 50 Enzyme (EC, Enzyme, Reaction)
3524* 50 Phenotype (Phenotype, Omim)
2490 50 Organization (Component, Complex, Assembly, Entity)
1849 49 Interaction (Interaction, Experiment, Strength)
2897 49 Cell Line (Cell, Line, Tissue, Type, Node)
6283 39 Organism (Organism, Host, Entity)
2911 38 Ontology (Synonym, Term, Ontology)
1787 32 Evolution (Member, Family, Orthologue, Homologue, Evidence)
5695 31 Literature (Pubmed, Keyword)
Table 2. Primary composition of communities in terms of key biomedical concepts. (*) marked communities are visualized in
Figure 6.
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a biomedical perspective (e.g., for retrieving all DRUG–PROTEIN TARGET INTERACTIONS).
Similar Content across the LSLOD Cloud
As seen in Figure 6, several online sources have data and knowledge pertaining to ENZYME or PHENOTYPE entities but use
completely different schema elements. Communities of similar content depicted in Figure 6, while showcasing the different
schema element URIs to represent similar content, may also provide an idea on the different equivalence attribute URIs
used to link entities across different sources to a specific entity coding scheme. For example, the ENZYME entities in the
different sources of the LSLOD cloud are linked to the Enzyme Commission number (a numerical classification scheme for
enzymes) using different attribute URIs with labels such as EC CODE, EC NUMBER, X EC, and HAS EC NUMBER. Similarly,
PHENOTYPE entities are linked to the OMIM phenotype identifiers (i.e., Online Mendelian Inheritance in Man is a knowledge
base of human genes and genetic phenotypes87) using different attribute URIs with labels such as OMIM REFERENCE, X OMIM,
and HAS OMIM PHENOTYPE. Communities that are composed entirely of different attribute URIs referring entities in different
sources to a uniform coding scheme are also observed (e.g., ENSEMBL and HGNC Gene Coding scheme attributes). The
knowledge on the different equivalence attribute URIs could guide query federation methods to perform entity reconciliation
after the retrieval of information from multiple sources.
Through a manual inspection of such “identifier” communities (e.g., communities 1417 and 1632 in Table 2), we were
able to detect different URI representations for similar entities (classes and instances). A few examples of different URI
representations are shown in Table 3 for chemical entities of ChEBI6, PubChem5 and MeSH60 sources. Most linked data
querying architectures rely on the existence of exact URIs to query multiple sources simultaneously (using data warehousing,
link traversal or query federation methods)13, 26, 27. However, since these URIs are essentially different, querying architectures
will not be able to integrate data and knowledge from different sources (e.g., protein–ligand binding information from PDB and
biological assay experimental data from PubChem). These examples qualify as “intent for reuse” and add to the challenges of
semantic heterogeneity across the LSLOD cloud.
The use of word embeddings in the community detection algorithm enables the identification of mappings between similar
linked data schema elements (e.g., kegg:therapeutic-category↔ drugbank:Drug-Classification-Category: 0.93,
obo:regulates↔ drugbank:mechanism-of-action: 0.75, faldo:location↔ drugbank:cellular-location: 0.89).
These mappings may provide suggestions to linked data publishers and consumers on relevant information in different sources.
However, many of these mappings may not be accurate due to reliance on the word embeddings, as well as the 0.75 threshold
on the cosine similarity scores. For example, as seen in Figure 6, while the REACTION concept in the ENZYME community
symbolizes biochemical reactions where enzyme entities may act as catalyzing agents, an error with the community detection
algorithm also indicates that ADVERSE REACTION (clinical concept observed in patients treated with a set of drugs) may be a
part of this community. This is due to the fact that the singular schema element pertaining to ADVERSE REACTION from an
RDF graph in the Linked Life Data project55 is linked to schema elements pertaining to BIOCHEMICAL REACTION (i.e., the
edges have a cosine similarity score of more than 0.75).
Intent for Reuse across the LSLOD Cloud
A few linked data sources do reuse content from existing biomedical ontologies, but in many cases the reuse is limited to very
few classes or involve incorrect representations. Previously, we have documented similar cases to be “intent for reuse” on
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Entity Origin URI Representation Sources
ChEBI http://purl.obolibrary.org/obo/CHEBI/* LinkedSPL, PubChem, NBDC
ExpresssionAtlas, BioSamples
http://identifiers.org/chebi/CHEBI: BioModels, PDB, WikiPathways
Bio2RDF, PathwayCommons
http://identifiers.org/obo.chebi/CHEBI: BioModels, BioPax, WikiPathways
http://www.ebi.ac.uk/chebi/ PDB, ChEMBL
http://bio2rdf.org/chebi: Bio2RDF
PubChem http://identifiers.org/pubchem.compound/ Bio2RDF, WikiPathways, NBDC
Compound http://rdf.ncbi.nlm.nih.gov/pubchem/compound/* WikiPathways, PubChem
http://bio2rdf.org/pubchem.compound: Bio2RDF
http://pubchem.ncbi.nlm.nih.gov/compound/ NBDC
MeSH http://purl.bioontology.org/ontology/MESH/* NBDC, PDB, LinkedSPL
http://id.nlm.nih.gov/mesh/YEAR/* MeSH, DisGenet, PDB
http://identifiers.org/mesh/ Bio2RDF, DisGenet, PDB
http://www.ncbi.nlm.nih.gov/mesh/ BioSamples
http://rdf.imim.es/rh-mesh.owl# DisGenet
http://bio2rdf.org/mesh_resource: Bio2RDF
http://bio2rdf.org/mesh: Bio2RDF
Table 3. Different kinds of URI representations for chemical compounds observed in LD Sources. (*) marks the
recommended representation(s).
the part of ontology engineers in the biomedical domains37. Table 3 documents similar cases of intent for reuse that were
observed across the biomedical linked data sources. Essentially, these URI patterns generally have the same identifier and
source ontology or vocabulary, but are reused from different versions of the source ontology or vocabulary, or represented
using different notations or namespaces. These patterns cannot be considered as actual reuse, as these are different, and often
incorrect, representations for the same terms, and no explicit mappings are found. Hence, the advantages of reuse cannot be
experienced. By using the correct representations, the semantic heterogeneity (i.e., content overlap) can be reduced substantially.
However, ontology engineers and linked data publishers may lack sufficient guidelines and tools to perform these tasks. These
examples severely hinder most query federation and link traversal methods for heterogeneous data and knowledge integration
on the Life Sciences Linked Open Data cloud.
For a more concrete example on how intent for reuse and semantic heterogeneity hampers link traversal and query federation
across the LSLOD cloud, consider the user query “Retrieve Assays which identify potential Chemopreventive Agents that
have Molecular Weight < 300 g/mol and target Estrogen Receptor present in Human.” This query requires the retrieval of
knowledge from the Kyoto Encyclopedia of Genes and Genomes (KEGG) knowledge base9 on all the chemicals that target
ESTROGEN RECEPTOR protein, and then the retrieval of assay data on these chemicals from the ChEMBL chemical bioactivity
repository52. The KEGG knowledge base and the ChEMBL data repository are both published on the LSLOD cloud33, 50,
and have chemical URIs that have x-ref links to chemical URIs in the ChEBI ontology of biological chemicals6. However,
since Bio2RDF KEGG uses the URI representation scheme http://bio2rdf.org/chebi:* and ChEMBL uses the URI
representation scheme http://purl.obolibrary.org/obo/CHEBI/* for the same identifiers in the ChEBI ontology (Table
3), it is impossible to formulate a federated SPARQL query that can query KEGG and ChEMBL, simultaneously and retrieve
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the relevant results in an integrated fashion.
Increasing the reuse of schema elements from existing vocabularies and ontologies may decrease semantic heterogeneity
and enable the integrated querying of multiple data and knowledge sources across the LSLOD cloud using the Semantic Web
technologies. In cases where linked data publishers have the need to use a custom vocabulary or ontology, the overarching
advice would be to publish this vocabulary or ontology to a popular repository, so other publishers can use these sources.
Conclusion
Semantic Web and linked data technologies garner significant interest and investment from the biomedical research community
toward tackling the diverse challenges of heterogeneous biomedical data and knowledge integration. In this paper, we conduct
an empirical meta-analysis to demonstrate that there is considerable heterogeneity and discrepancy in the quality of Life
Sciences Linked Open Data (LSLOD) sources on the Web, which are published using the above technologies. We discuss
on whether the LSLOD cloud can truly be considered “linked” due to the heterogeneous schemas, varying entity notations,
the lack of mappings between similar entities, and the lack of reuse of common vocabularies. While increasing reuse across
biomedical ontologies and linked data sources is definitely considered to be an attractive alternative to decrease semantic
heterogeneity, it will take a while for biomedical ontology developers and linked data publishers to realize the incentives of
reuse and actually embrace the guidelines and best practices while publishing data and knowledge. Actual reuse through the
use of correct URI representations in biomedical ontologies and linked data sources, rather than intent to reuse, can decrease
semantic heterogeneity substantially itself. The findings from our meta-analysis across the LSLOD cloud, as well as the
resources such as the LSLOD schema graph made available through this research, will lead to the development of better tools
and methods to increase vocabulary reuse and enable efficient querying and integration of multiple heterogeneous biomedical
sources on the Web.
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Supplementary Material
The Extraction algorithm uses a set of SPARQL query templates (Listing 2) to extract schemas (e.g., classes, properties,
domains, ranges) as well as sample instances of the classes and their property values from the SPARQL endpoints in the
LSLOD Cloud. The input of the Extraction algorithm is the SPARQL endpoint and its version, which can be automatically
detected from a SPARQL endpoint based on the queries and keywords supported. These schema elements are further annotated
with few characteristics that their instances can undertake (e.g., namespaces, regular expression patterns of the instance URIs,
type of attribute datatypes). The Extraction algorithm is presented in Algorithm 1.
------------------ SPARQL QUERY 1 ------------------
SELECT DISTINCT ?g WHERE {
GRAPH ?g { ?s ?p ?o }
}
------------------ SPARQL QUERY 2 ------------------
SELECT ?Concept (COUNT (?x) AS ?cCount) WHERE {
GRAPH <GRAPH_URI> { ?x rdf:type ?Concept }
} GROUP BY ?Concept ORDER BY DESC(?cCount)
------------------ SPARQL QUERY 3 ------------------
SELECT DISTINCT ?p ?c (COUNT(?x) AS ?count) ?valType WHERE {
GRAPH <GRAPH_URI> { ?x rdf:type <CONCEPT_URI>; ?p ?o .
OPTIONAL {?o rdf:type ?c} .
FILTER(!(?p = ’rdf:type’)) .
BIND(DATATYPE(?o) AS ?valType) }
} GROUP BY ?p ?c ?valType ORDER BY DESC(?count)
------------------ SPARQL QUERY 4 ------------------
SELECT ?x WHERE {
GRAPH <GRAPH_URI> { ?x rdf:type <CONCEPT_URI> }
} ORDER BY RAND() LIMIT 2000
------------------ SPARQL QUERY 5 ------------------
SELECT ?x WHERE {
GRAPH <GRAPH_URI> { ?c rdf:type <CONCEPT_URI>; <PROPERTY_URI> ?x }
} ORDER BY RAND() LIMIT 2000
Listing 2. SPARQL Query templates to extract schema descriptions from the LSLOD Cloud
As shown in Algorithm 1, the extractor decides on the set of SPARQL query templates to execute against the input
SPARQL endpoint given its version (Step 2). The extractor queries the SPARQL endpoint and extracts the set of graph URIs
for all named RDF Graphs NG exposed through the SPARQL endpoint (Step 3, SPARQL Query SQ1). For each graph URI,
the extractor extracts the set of classes C and the total number of instances for each class k(C) (Step 7, SQ2). The extractor
identifies the properties P for which a specific class serves as the domain for all assertions, and also retrieves the range classes
r(P) for object properties, or the datatypes dt(P) for data properties (Step 12, SQ3). The Extraction algorithm also extracts
a random sample (without replacement) of 2,000 instances for each class (Step 9, SQ4) and 2,000 property assertions (Step
14, SQ5) for a class–property combination, and generates summary characteristics (e.g.is_categorical, datatype, namespace,
median length) of the data.
The Extraction algorithm accounts for different versions of SPARQL supported at the remote SPARQL endpoints using a
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‘version’ parameter input v(SE). Depending on the SPARQL version, certain SPARQL constructs such as BIND and GROUP
BY may not be supported, and alternative SPARQL queries are formulated (not shown here). Alternative SPARQL queries are
also formulated if the remote endpoint times out while query processing.
Classes, properties, and datatypes, are represented as nodes in the schema graph GT −Box extracted by the Pattern Miner
(Steps 11, 17, 18, 21, 22). The edges link property nodes to class nodes and datatype nodes depending on the domain and
range descriptions of the corresponding property (Steps 19 and 23). The nodes and edges are annotated by the count (k(C)
and k(P)) and summary characteristics of corresponding instances or property assertions respectively (Steps 11, 19, 23). This
schema graph is a fragment of the actual T -Box of the RDF graph. The GT −Box graphs extracted for all RDF named graphs
NG in the LSLOD cloud are merged to generate the schema graph GLSLOD of the entire LSLOD cloud.
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Algorithm 1: LSLOD Schema Extraction Algorithm
1 function EXTRACTOR (SE ,v(SE));
Input :A SPARQL Endpoint URI SE and the supported version v(SE)
Output :A dictionary of (graph URIs, schema (T -Box) fragments, each represented as a graph GT −Box), extracted from
the SPARQL endpoint SE
/* Generate SPARQL Queries given the version of the endpoint (Listing 2) */
2 {SQi|i = 1,2, . . . ,5}←SPARQL_QUERIES(v(SE));
/* Extract all the Graph URIs */
3 {URIg}← SQ1 (SE) ;
/* An empty dictionary to store the Graph URIs and T-Box schema fragments */
4 SF ←{} ;
5 for urig ∈ {URIg} do
6 GT −Box←∅ ;
7 C,k(C)← SQ2(SE ,urig) ;
8 for c ∈ C do
/* Extract a randomized sample of 2000 instances */
9 A(c)−2000← SQ4(SE ,urig,c);
/* Generate a data summary of the instances */
10 sumc←SUMMARIZE(A(c)−2000) ;
11 Add node to GT −Box with URI c, Type class, Count k(c) and Summary sumc ;
12 P ,r(P),dt(P),k(P)← SQ3(SE ,urig,c) ;
13 for p ∈ P do
/* Extract a randomized sample of 2000 assertions */
14 A(c,p)−2000← SQ5 (SE ,urig,c, p);
/* Generate a data summary of the assertions */
15 sumcp←SUMMARIZE(A(c)−2000) ;
/* Data property if range URI is missing, else Object property */
16 if r(p) =∅ then
17 Add node to GT −Box with URI p, Type data property;
18 Add node to GT −Box with URI dt(p), Type datatype;
19 Add edges c→ p and p→ dt(p) to GT −Box, with Count k(p) and Summary sumcp;
20 else
21 Add node to GT −Box with URI p, Type ob ject property;
22 Add node to GT −Box with URI r(p), Type class;
23 Add edges c→ p and p→ r(p) to GT −Box, with Count k(p) and Summary sumcp;
24 end
25 end
26 end
27 SF [urig]← GT −Box ;
28 end
29 return SF ;
32/32
